Data de publicação: 13/05/2022 - 16:36
During a visit to Fiocruz last Friday (6 May), the World Health Organization's (WHO) technical lead for COVID-19 response, Maria Van Kerkhove, debated the learnings and challenges necessary to maintain investments that were focused on the pandemic's preparedness for possible new public health emergencies. After getting to know more about the Foundation’s actions and visiting the Laboratory for Measles and Respiratory Viruses of the...
Notícias
Data de publicação: 13/05/2022 - 14:58
The complex dynamic of public health on Brazil’s borders with other South American countries and with the French Overseas Department of French Guiana is a challenge that must be faced in an increasingly integrated way with the different players that make up the health systems in these areas, on both sides of the international frontier. It was in the attempt to improve this relationship and to plan joint actions that representatives of the...
Notícias
Data de publicação: 10/05/2022 - 16:00
Beatriz Grinsztejn, infectiologist and head of the Laboratory of Clinical Research in STD and AIDS of the National Institute of Infectiology (INI/Fiocruz), received last Thursday (5/5), the award HIV Vaccine Network Service Award, granted during a 2022 HVTN/CoVPN Full Group Meeting, in Washington, USA. The award was given in recognition of her outstanding contribution to the network. The HIV Vaccine Trials Network (HVTN), based in Seattle, is...
Notícias
Data de publicação: 09/05/2022 - 15:07
On April 26, Fiocruz received a visit from the director of the Jenner Institute, University of Oxford, Adrian Hill. Within the scope of the Foundation's Deliberative Council, he was given a plaque in gratitude to him and his university team for the development of the Oxford/Astrazeneca vaccine, today produced 100% nationally at the Institute of Technology in Immunobiological (Bio-Manguinhos/ Fiocruz), after technology transfer. Then, the...
Notícias
Data de publicação: 09/05/2022 - 14:08
Through its Institute of Drug Technology (Farmanguinhos), Fiocruz signed last Tuesday (May 3) an agreement of technological cooperation with American pharmaceutical company MSD (Merck Sharp & Dohme). The goal is to manufacture in Brazil the first oral antiviral drug to treat COVID-19. Last Wednesday (May 4) afternoon, Brazil’s National Agency for Health Surveillance (Anvisa) released the authorization to use the drug in the country on...
Notícias
Data de publicação: 28/04/2022 - 15:05
“There are many nuclear missiles in the world. Why don’t we have enough plants to produce vaccines?” The demand came from Adrian Hill, director of the Jenner Institute, of the University of Oxford. One of the main developers of the Oxford/AstraZeneca COVID-19 vaccine, Hill attended the Symposium on Emerging and Persisting Global Health Threats, organized by Fiocruz and by the National Institute of Allergy and Infectious...
Notícias
Data de publicação: 26/04/2022 - 16:04
The Leônidas & Maria Deane Institute (Fiocruz Amazônia), in a partnership with the Tropical Medicine Foundation (FMT), is participating in a pre-clinical trial project for a vaccine against the vivax variety of malaria. The project has just had its sponsoring approved by the Global Health Innovative Technology Fund (GHIT) of Japan. The research is coordinated by researcher Shigeto Yoshida, of the University of Kanazawa, and its...
Notícias
Data de publicação: 26/04/2022 - 15:15
Fiocruz Ceará will welcome a researcher from Pasteur Institute and begin integrated research works aiming at setting up the Fiocruz-Pasteur Platform at the Oswaldo Cruz Foundation campus in Eusébio, in Fortaleza’s Metropolitan Area, in the state of Ceará. The announcement was made by the representative of the Ministry for Europe and Foreign Affairs of France, Leandro Batista, during the event that gathered scientists...
Notícias
Data de publicação: 25/04/2022 - 15:40
For the World Chagas Disease Day, celebrated on April 14, Fiocruz organized a series of activities last week. Among the actions are two online events with lectures and debates about the challenges and possibilities to fight the disease. Last Monday, on one of these occasions, the theme series Memorias of the Oswaldo Cruz Institute was launched, with 15 reflection papers by authors from all over the world and from different areas of knowledge...
Notícias
Data de publicação: 14/04/2022 - 14:16
Last Monday, April 11, was the first day of the international workshop Innovation by Entrepreneurship, promoted by Fiocruz in a partnership with the Pasteur Institute. The purpose of the event, which will continue on Tuesday, April 12, is to present the results of entrepreneurship initiatives of both institutions and to promote a debate between their researchers. Marco Krieger, Fiocruz vice-president of Production and Innovation in Health,...
Notícias
Data de publicação: 13/04/2022 - 15:05
Delegations from the Danish government and the National Institute of Industrial Property (Inpi) visited Fiocruz last Wednesday (4/6) as part of cooperation activities for innovation in Health between Brazil and the European country. The cooperation relationship is in phase 2, dedicated to the health issue, and, following an invitation from Inpi, Fiocruz has been participating in the project. The Foundation's delegations and representatives...
Notícias
Data de publicação: 12/04/2022 - 17:58
A new study by Fiocruz, published in Lancet Infectious Diseases last Thursday (March 31), shows that even people with previous infection by Sars-CoV-2 have higher protection levels when vaccinated. The highest effectiveness was observed with the four vaccines in use in Brazil (Coronavac, AstraZeneca, Janssen, and Pfizer-BioNTech) in the prevention of COVID-19. The research shows increased protection against infection and, in particular, against...
Notícias
Data de publicação: 12/04/2022 - 17:33
Released this Friday (April 4), the Fiocruz COVID-19 Observatory Report shows maintenance of the falling trend of COVID-19 incidence and mortality indicators. The document highlights that for the first time since May 2020, no Brazilian state has exceeded 0.3 deaths per 100,000 inhabitants. The researchers state that according to these new data it is possible to say that the third epidemic wave in Brazil, with a predominance of Omicron among the...
Notícias
Data de publicação: 12/04/2022 - 12:16
Fiocruz hosted, on March 21st, 2022, a meeting that celebrated the victorious partnership in the field of health surveillance. In November 2021, the city of São José dos Pinhais, in the state of Paraná, received the Guangzhou award along with nine other towns around the world. The award selects innovatives approaches adopted by local and regional governments to reach the Sustainable Development Goals (SDG), thus improving...
Notícias
Data de publicação: 08/04/2022 - 15:33
Last Tuesday (March 29), Fiocruz and Drugs for Neglected Diseases initiative (DNDi) signed a Memorandum of Understanding for dengue fever research and treatment. The occasion also sealed a Strategic Research Alliance between the two institutions and the joint submission of a project to the Finep Public Call for Neglected Diseases.
In addition to signing the Memorandum of Understanding for dengue fever, the occasion sealed a Strategic...
Notícias
Data de publicação: 04/04/2022 - 12:55
The international partnerships at Fiocruz are governed by various collaborative agreements. The following is a list of the agreements currently in force.
North-South
In France, FIOCRUZ is the only Brazilian institution that belongs to the Pasteur World Network, which maintains projects with the Alliance Nationale pour les Sciences de la Vie et la Santé (Aviesan), a French national institution that includes the Institut...
Páginas Institucionais (antigas)
Data de publicação: 04/04/2022 - 12:54
The operational activities pertaining to international exchange feature drafting agreements, contracts, and/or memoranda of understanding with institutions from partner countries, procedures for time spent abroad, orientation on applications for special passports and requests for third party notes, and receiving foreign colleagues at the Foundation.
International Agreements
These are formal instruments for establishing and strengthening...
Páginas Institucionais (antigas)
Data de publicação: 31/03/2022 - 18:30
The implementation of a World Health Organization (WHO) hub for Pandemic and Epidemic Intelligence led the WHO to organize the visit of a top-level delegation, together with the Pan-American Health Organization (PAHO), to Fiocruz last Thursday (March 24). Led by the assistant director-general of the Division of Intelligence and Surveillance Systems for Emergencies in Health, Chikwe Ihekweazu, who is also the director of the hub, and Socorro...
Notícias
Data de publicação: 30/03/2022 - 10:15
In a meeting promoted on March 28, by the Center for International Relations in Health (Cris/Fiocruz) and the Vice-Presidencies of Research and Biological Collections (VPPCB) and Education, Information and Communication (VPEIC), members of the Consulate General of the United States in Rio de Janeiro continued the partnership process initiated in 2021. The aim is to expand scientific cooperation between Fiocruz and American institutions....
Notícias
Data de publicação: 25/03/2022 - 16:07
By means of the Immunobiological Technology Institute (Bio-Manguinhos), Fiocruz has been selected by the Ministry of Health to represent Brazil at the BRICS Center of Vaccine Research and Development. Launched this Tuesday (March 22) by the group of countries made up by Brazil, Russia, India, China and South Africa, the goal of the initiative is to share experiences, information and training, so as to strengthen the productive capacity of the...
Notícias
Data de publicação: 24/03/2022 - 15:43
At a meeting that took place last Friday (March 19), representatives of Fiocruz and of the Deutsche Forschungsgemeinschaft (DFG), a German non-profit organization that stimulates research, got together to strengthen bilateral cooperation between the institutions and to discuss possible foment partnerships. As a first step in this direction, a workshop was suggested to evaluate the opportunities, identifying possibilities among ongoing projects...
Notícias
Data de publicação: 23/03/2022 - 16:44
Unitaid, the global health agency connected to the WHO, will be financing the implementation of the project for Injectable Pre-Exposure Prophylaxy in Brazil, using long-acting Cabotegravir. With only six injections per year, the method has proven to be more effective than daily oral PrEP in terms of reducing the risk of infection by the virus. The project will be coordinated by the Evandro Chagas National Infectiology Institute (INI/Fiocruz) in...
Notícias
Data de publicação: 23/03/2022 - 16:42
A study by researchers of Fiocruz and of the University of Columbia has identified promising results in a combination of antiviral drugs for the treatment of COVID-19. Scientists showed that there is a synergy between the substances, inhibiting the enzymes that allow Sars-CoV-2 to multiply more effectively. Together, the drugs may reduce viral replication about ten times more than if taken separately.
The drugs studied are already...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
